Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes Mellitus

Figure 2

Relationship between the baseline HbA1c and changes in HbA1c after six months of exenatide therapy. Results are shown with the equation for the line of best fit, the value quantifying the goodness of fit, and the value showing statistical significance. Dashed line indicates the 11 mmol/mol point which is the reduction required for individuals to be classed as responders to exenatide. Abbreviations: HbA1c, glycated haemoglobin.